Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives.
暂无分享,去创建一个
[1] G. Berglund,et al. Low-Dose Metoprolol CR/XL and Fluvastatin Slow Progression of Carotid Intima-Media Thickness: Main Results From the &bgr;-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) , 2001, Circulation.
[2] J. Salonen,et al. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.
[3] S. Priori,et al. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension , 2003, Heart Drug.
[4] T. Lakka,et al. Cardiorespiratory Fitness and the Progression of Carotid Atherosclerosis in Middle-Aged Men , 2001, Annals of Internal Medicine.
[5] T. Chou,et al. Association of Pravastatin and Left Ventricular Mass in Hypercholesterolemic Patients: Role of 8-Iso-Prostaglandin F2&agr; Formation , 2002, Journal of cardiovascular pharmacology.
[6] S. Tretli,et al. Blood Pressure Levels in Treated Hypertensive Patients in General Practice in Norway , 2001, Blood pressure.
[7] J. Spinelli,et al. The Extensive Lifestyle Management Intervention (ELMI) following cardiac rehabilitation trial. , 2003, European heart journal.
[8] I. Holme,et al. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. , 1997, European heart journal.
[9] C. Furberg,et al. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) , 1995, The American journal of cardiology.
[10] M. Trip,et al. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial , 2001, The Lancet.
[11] J F Sallis,et al. Compendium of physical activities: classification of energy costs of human physical activities. , 1993, Medicine and science in sports and exercise.
[12] G. Berglund,et al. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[13] H. Boudoulas,et al. Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients , 2003, Current medical research and opinion.
[14] J. Croft,et al. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. , 2000, American heart journal.
[15] S. Anderssen,et al. Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES). , 1995, Blood pressure.
[16] S P Azen,et al. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness. , 1997, The American journal of clinical nutrition.
[17] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[18] T Gustavsson,et al. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. , 1997, Stroke.
[19] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[20] R. Collins,et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial , 2003, The Lancet.
[21] R. Collins,et al. Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.
[22] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[23] A. Gotto,et al. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). , 1997, The American journal of cardiology.
[24] M. Stugaard,et al. M‐mode echocardiographic findings in apparently healthy, non‐athletic Norwegians aged 20–70 years. Influence of age, sex and body surface area , 1989, Journal of internal medicine.
[25] C. Drevon,et al. Response rates with different distribution methods and reward, and reproducibility of a quantitative food frequency questionnaire , 1997, European Journal of Clinical Nutrition.
[26] C. Furberg,et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. , 1994, Circulation.
[27] C. Bouchard,et al. Effects of Aerobic Physical Exercise on Inflammation and Atherosclerosis in Men: The DNASCO Study , 2004, Annals of Internal Medicine.
[28] B. Fagerberg,et al. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima‐media thickness and clinical outcome during 6 years of follow‐up , 2001, Journal of internal medicine.
[29] J. Mckenney,et al. Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysis. , 2001, Clinical therapeutics.
[30] L. Lindholm. Cardiovascular risk factors and their interactions in hypertensives. , 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[31] B. Hustvedt,et al. Registration of physical activity and energy expenditure Validity control of a questionnaire , 2000 .